%0 Figure %A Lundberg, Arian %A Lindström, Linda %A Li, Jingmei %A Harrell, J. %A Darai-Ramqvist, Eva %A Sifakis, Emmanouil %A Foukakis, Theodoros %A Perou, Charles %A Czene, Kamila %A Bergh, Jonas %A Tobin, Nicholas %D 2019 %T Additional file 2: of The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours %U https://springernature.figshare.com/articles/figure/Additional_file_2_of_The_long-term_prognostic_and_predictive_capacity_of_cyclin_D1_gene_amplification_in_2305_breast_tumours/7790774 %R 10.6084/m9.figshare.7790774.v1 %2 https://springernature.figshare.com/ndownloader/files/14500016 %K CCND1 gene amplification %K Gene expression %K Breast cancer %K PAM50 %K Luminal A %K CDK4/6 %K BCSS %X Figure S2. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as a clinical end point for all patients of cohort 1 split by PAM50 subtypes and treatments. (A) Luminal A, (B) luminal B, (C) HER2-enriched, (D) basal-like, (E) endocrine therapy, (F) chemotherapy, (G) both chemotherapy and endocrine combined, (H) untreated patients. P values refer to log-rank tests. (TIF 3311 kb) %I figshare